Multiple Myeloma: A New Treatment Option for Newly Diagnosed, Transplant-Ineligible Patients
This supplement is sponsored by Janssen Biotech, Inc.
November 4, 2019|Hematology and Oncology
Saad Z. Usmani, MD, FACP, discusses a new treatment option for newly diagnosed, transplant-ineligible patients with multiple myeloma.
Article includes:
- An important option for patients with multiple myeloma
- Details on the phase 3 trial
- Efficacy and safety profile
,
